id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0525-0013,FDA,FDA-2008-D-0525,New Contrast Imaging Indication Considerations for Devices and Approved Drug and Biological Products:  Guidance for Industry,Other,Guidance,2009-12-31T05:00:00Z,2009,12,2009-12-31T05:00:00Z,,2024-11-07T22:12:12Z,,1,0,0900006480a77652